Is there an association between cortical thickness, age of onset, and duration of illness in schizophrenia?

CNS Spectrums

Volumn 18, Issue 6, 2013, Pages 315-321

  Assunção Leme, Idaiane Batista ^a   Gadelha, Ary ^a   Sato, João Ricardo ^b   Ota, Vanessa Kiyomi ^a   De Jesus Mari, Jair ^a   Melaragno, Maria Isabel ^a   De Arruda Cardoso Smith, Marilia ^a   Belangero, Sintia Iole Nogueira ^a   Bressan, Rodrigo Affonseca ^a   Jackowski, Andrea Parolin ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDADE FEDERAL DO ABC   (Brazil)

Author keywords

Age; age at onset; cortical thickness; duration of illness; frontal lobe; schizophrenia

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN SIZE; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); DISEASE DURATION; FEMALE; FRONTAL CORTEX; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OCCIPITAL CORTEX; ONSET AGE; PARIETAL CORTEX; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; TEMPORAL CORTEX; YOUNG ADULT;

EID: 84890059136     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852913000333     Document Type: Article

References (38)

1. Jung WH, Kim JS, Jang JH, et al. Cortical thickness reduction in individuals at ultra-high-risk for psychosis. Schizophr Bull. 2011; 37(4): 839-849.
2. Honea R, Crow T, Passingham D, Mackay CE. Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry. 2005; 162(12): 2233-2245.
3. Kuperberg GR, Broome MR, McGuire PK, et al. Regionally localized thinning of the cerebral cortex in schizophrenia. Arch Gen Psychiatry. 2003; 60(9): 878-888.
4. Nesvåg R, Lawyer G, Varnäs K, et al. Regional thinning of the cerebral cortex in schizophrenia: effects of diagnosis, age and antipsychotic medication. Schizophr Res. 2008; 98(1-3): 16-28.
5. Wright IC, Rabe-Hesketh S, Woodruff PW, et al. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry. 2000; 157(1): 16-25.
6. Lieberman J, Chakos M, Wu H, et al. Longitudinal study of brain morphology in first episode schizophrenia. Biol Psychiatry. 2001; 49(6): 487-499.
7. DeLisi LE, Sakuma M, Maurizio AM, et al. Cerebral ventricular change over the first 10 years after the onset of schizophrenia. Psychiatry Res. 2004; 130(1): 57-70.
8. Vita A, De Peri L, Silenzi C, et al. Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophr Res. 2006; 82(1): 75-88.
9. Crespo-Facorro B, Roiz-Santianez R, Perez-Iglesias R, et al. Specific brain structural abnormalities in firstepisode schizophrenia: a comparative study with patients with schizophreniform disorder, nonschizophrenic non-affective psychoses and healthy volunteers. Schizophr Res. 2009; 115(2-3): 191-201.
10. Crespo-Facorro B, Roiz-Santianez R, Perez-Iglesias R, et al. Global and regional cortical thinning in firstepisode psychosis patients: relationships with clinical and cognitive features. Psychol Med. 2011; 41(7): 1449-1460.
11. Olabi B, Ellison-Wright I, McIntosh AM, et al. Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biol Psychiatry. 2011; 70(1): 88-96.
12. Weinberger DR, McClure RK. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? Arch Gen Psychiatry. 2002; 59(6): 553-558.
13. Kähler AK, Rimol LM, Brown AA, et al. Effect of DISC1 SNPs on brain structure in healthy controls and patients with a history of psychosis. Am J Med Genet B Neuropsychiatr Genet. 2012; 159B(6): 722-730.
14. Dorph-Petersen KA, Pierri JN, Perel JM, et al. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology. 2005; 30(9): 1649-1661.
15. Roiz-Santiáñez R, Tordesillas-Gutiérrez D, Ortíz-García de la Foz V, et al. Effect of antipsychotic drugs on cortical thickness: a randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine. Schizophr Res. In press. DOI: 10.1016/j.schres. 2012.07.014.
16. Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A. 2000; 97(20): 11050-11055.
17. Schultz CC, Koch K, Wagner G, et al. Complex pattern of cortical thinning in schizophrenia: results from an automated surface based analysis of cortical thickness. Psychiatry Res. 2010; 182(2): 134-140.
18. Premkumar P, Kumari V, Corr PJ, et al. Frontal lobe volumes in schizophrenia: effects of stage and duration of illness. J Psychiatr Res. 2006; 40(7): 627-637.
19. Matsumoto H, Simmons A, Williams S, et al. Superior temporal gyrus abnormalities in early-onset schizophrenia: similarities and differences with adult-onset schizophrenia. Am J Psychiatry. 2001; 158(8): 1299-1304.
20. van Haren NE, Schnack HG, Cahn W, et al. Changes in cortical thickness during the course of illness in schizophrenia. Arch Gen Psychiatry. 2011; 68(9): 871-880.
21. van Haren NE, Cahn W, Hulshoff Pol HE, Kahn RS. Confounders of excessive brain volume loss in schizophrenia. Neurosci Biobehav Rev. In press. DOI: 10.1016/j.neubiorev.2012.09.006.
22. Bose SK, Mackinnon T, Mehta MA, et al. The effect of ageing on grey and white matter reductions in schizophrenia. Schizophr Res. 2009; 112(1-3): 7-13.
23. Fischl B, Salat DH, Busa E, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002; 33(3): 341-355.
24. Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. II: inflation, flattening, and a surface-based coordinate system. Neuroimage. 1999; 9(2): 195-207.
25. Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A. 2000; 97(20): 11050-11055.
26. Panizzon MS, Fennema-Notestine C, Eyler LT, et al. Distinct genetic influences on cortical surface area and cortical thickness. Cereb Cortex. 2009; 19(11): 2728-2735.
27. Ecker C, Marquand A, Mourão-Miranda J, et al. Describing the brain in autism in five dimensions: magnetic resonance imagingassisted diagnosis of autism spectrum disorder using a multiparameter classification approach. J Neurosci. 2010; 30(32): 10612-10623.
28. Huttenlocher PR. Morphometric study of human cerebral cortexdevelopment. Neuropsychologia. 1990; 28(6): 517-527.
29. Sowell ER, Thompson PM, Leonard CM, et al. Longitudinal mapping of cortical thickness and brain growth in normal children. J Neurosci. 2004; 24(38): 8223-8231.
30. Rakic P. Defects of neuronal migration and the pathogenesis of cortical malformations. Prog Brain Res. 1988; 73: 15-37.
31. Armstrong E, Schleicher A, Omran H, Curtis M, Zilles K. The ontogeny of human gyrification. Cereb Cortex. 1995; 5(1): 56-63.
32. Kubota M, Miyata J, Yohida H, et al. Age-related cortical thinning in schizophrenia. Schizophr Res. 2011; 125(1): 21-29.
33. McGinnis SM, Brickhouse M, Pascual B, Dickerson BC. Age-related changes in the thickness of cortical zones in humans. Brain Topogr. 2011; 24(1): 279-291.
34. Velakoulis D, Wood SJ, Smith DJ, et al. Increased duration of illness is associated with reduced volume in right medial temporal/anterior cingulate grey matter in patients with chronic schizophrenia. Schizophr Res. 2002; 57(1): 43-49.
35. Premkumar P, Fannon D, Kuipers E, et al. Association between a longer duration of illness, age and lower frontal lobe grey matter volume in schizophrenia. Behav Brain Res. 2008; 193(1): 132-139.
36. Kumra S, Schulz SC. Editorial: research progress in earlyonset schizophrenia. Schizophr Bull. 2008; 34(1): 15-17.
37. Berberian AA, Trevisan BT, Moriyama TS, et al. Working memory assessment in schizophrenia and its correlation with executive functions ability. Rev Bras Psiquiatr. 2009; 31(3): 219-226.
38. Goldman-Rakic PS, Selemon LD. Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr Bull. 1997; 23(3): 437-458.